Elastic N.V. Is Being Sued For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm — Neutral
ESTC Accesswire — February 13, 2025LOS ANGELES, CA / ACCESS Newswire / February 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Elastic N.V. ("Elastic" or "the Company") (NYSE:ESTC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
The Schall Law Firm Invites Shareholders With Losses In Pactiv Evergreen Inc. To Join A Securities Fraud Investigation — Neutral
PTVE Accesswire — February 13, 2025LOS ANGELES, CA / ACCESS Newswire / February 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Pactiv Evergreen Inc. ("Pactiv Evergreen" or "the Company") (NASDAQ:PTVE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Pactiv Evergreen board breached its fiduciary duties to shareholders.
The Schall Law Firm Invites Shareholders With Losses In Southwest Airlines Co. To Join A Securities Fraud Investigation — Neutral
LUV Accesswire — February 13, 2025LOS ANGELES, CA / ACCESS Newswire / February 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Southwest Airlines Co. ("Southwest Airlines" or "the Company") (NYSE:LUV) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Invites Investors With Losses In Alto Neuroscience, Inc. To Join A Securities Fraud Investigation — Neutral
ANRO Accesswire — February 13, 2025LOS ANGELES, CA / ACCESS Newswire / February 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Alto Neuroscience, Inc. ("Alto Neuroscience" or "the Company") (NYSE:ANRO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Invites Shareholders With Losses In Medpace Holdings, Inc. To Join A Securities Fraud Investigation — Neutral
MEDP Accesswire — February 13, 2025LOS ANGELES, CA / ACCESS Newswire / February 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
TKO Group Holdings, Inc. Is Being Investigated For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm — Neutral
TKO Accesswire — February 13, 2025LOS ANGELES, CA / ACCESS Newswire / February 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in TKO Group Holdings, Inc. ("TKO" or "the Company") (NYSE:TKO) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the TKO board breached its fiduciary duties to shareholders.
Levi & Korsinsky Reminds AstraZeneca PLC Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025 - AZN — Neutral
AZN Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/astrazeneca-plc-lawsuit-submission-form?prid=129300&wire=1 or contact Joseph E. Levi, Esq.
Shareholders that lost money on Applied Therapeutics, Inc. (APLT) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More — Neutral
APLT Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129299&wire=1 or contact Joseph E. Levi, Esq.
Shareholders that lost money on TELUS International (Cda) Inc. (TIXT) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More — Neutral
TIXT Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your TELUS International (Cda) Inc. (NYSE:TIXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/telus-international-lawsuit-submission-form?prid=129298&wire=1 or contact Joseph E. Levi, Esq.
The Schall Law Firm Invites Investors With Losses In Vacasa, Inc. To Join A Securities Fraud Investigation — Neutral
VCSA Accesswire — February 13, 2025LOS ANGELES, CA / ACCESS Newswire / February 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Vacasa, Inc. ("Vacasa" or "the Company") (NASDAQ:VCSA) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Vacasa board breached its fiduciary duties to shareholders.
Dave Inc. Is Being Investigated For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm — Neutral
DAVE Accesswire — February 13, 2025LOS ANGELES, CA / ACCESS Newswire / February 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Dave Inc. ("Dave" or "the Company") (NASDAQ:DAVE) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Electronic Arts Inc. Is Being Investigated For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm — Neutral
EA Accesswire — February 13, 2025LOS ANGELES, CA / ACCESS Newswire / February 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Electronic Arts Inc. ("EA" or "the Company") (NASDAQ:EA) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Invites Shareholders With Losses In Atara Biotherapeutics, Inc. To Join A Securities Fraud Investigation — Neutral
ATRA Accesswire — February 13, 2025LOS ANGELES, CA / ACCESS Newswire / February 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Atara Biotherapeutics, Inc. ("Atara" or "the Company") (NASDAQ:ATRA) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Carvana Co. Is Being Investigated For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm — Neutral
CVNA Accesswire — February 13, 2025LOS ANGELES, CA / ACCESS Newswire / February 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Carvana Co. ("Carvana" or "the Company") (NYSE:CVNA) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Transocean Ltd. Is Being Sued For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm — Neutral
RIG Accesswire — February 13, 2025LOS ANGELES, CA / ACCESS Newswire / February 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Transocean Ltd. ("Transocean" or "the Company") (NYSE:RIG) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
The Schall Law Firm Invites Investors With Losses To Join A Securities Fraud Case Against AstraZeneca PLC — Neutral
AZN Accesswire — February 13, 2025LOS ANGELES, CA / ACCESS Newswire / February 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AstraZeneca PLC ("AstraZeneca" or "the Company") (NASDAQ:AZN) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 23, 2022 and December 17, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 21, 2025.
TransMedics Group, Inc. Is Being Investigated For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm — Neutral
TMDX Accesswire — February 13, 2025LOS ANGELES, CA / ACCESS Newswire / February 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ:TMDX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Invites Investors With Losses To Join A Securities Fraud Case Against FTAI Aviation Ltd. — Neutral
FTAI Accesswire — February 13, 2025LOS ANGELES, CA / ACCESS Newswire / February 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FTAI Aviation Ltd. ("FTAI Aviation" or "the Company") (NASDAQ:FTAI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Regeneron Pharmaceuticals, Inc. Is Being Sued For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm — Neutral
REGN Accesswire — February 13, 2025LOS ANGELES, CA / ACCESS Newswire / February 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Regeneron Pharmaceuticals, Inc. ("Regeneron" or "the Company") (NASDAQ:REGN) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 2, 2023 and October 30, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before March 10, 2025.
Celanese Corporation Is Being Investigated For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm — Neutral
CE Accesswire — February 13, 2025LOS ANGELES, CA / ACCESS Newswire / February 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Celanese Corporation ("Celanese" or "the Company") (NYSE:CE) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
